Home Home > Browse Locations > Japan

Find Paid Clinical Trials in Japan

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in Japan

Top of Directory » All Locations » Japan


  • A Confirmatory Study of JNS020QD (Fentanyl) in Patients With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome

    Condition:   Pain
    Intervention:   Drug: Fentanyl; JNS020
    Sponsor:   Janssen Pharmaceutical K.K.
    Recruiting - verified November 2009

  • Study Evaluating Multiple Ascending Doses of ATN-103 in Japanese Subjects With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: ATN-103 10 mg q4wks;   Biological: ATN-103 30 mg q4wks;   Biological: ATN-103 80 mg q4wks;   Biological: ATN-103 10 mg q8wks;   Biological: ATN-103 80 mg q8wks
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • Metabolic Syndrome and Fingertip Endothelial Dysfunction

    Condition:   Metabolic Syndrome
    Intervention:   Other: Lifestyle instruction
    Sponsor:   Kumamoto University
    Active, not recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified October 2009

  • Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

    Condition:   Influenza Infection
    Intervention:   Dietary Supplement: tea catechin extracts
    Sponsors:   University of Shizuoka;   White Cross Nursing Home
    Recruiting - verified November 2009

  • A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

    Condition:   Spinocerebellar Degeneration
    Interventions:   Drug: KPS-0373;   Drug: Placebo
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

    Condition:   Overactive Bladder
    Interventions:   Drug: KUC-7483;   Drug: Placebo;   Drug: Tolterodine
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

    Condition:   Overactive Bladder
    Intervention:   Drug: KUC-7483
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Abatacept;   Drug: Abatacept;   Drug: Placebo
    Sponsor:   Bristol-Myers Squibb
    Not yet recruiting - verified October 2009

  • A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: LY2189265;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

    Condition:   Swine-Origin Influenza A H1N1 Virus
    Intervention:   Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
    Sponsors:   Novartis;   Novartis Vaccines
    Active, not recruiting - verified October 2009

  • Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients

    Conditions:   Neoplasms;   Metastatic Cancer;   Breast Cancer
    Interventions:   Drug: AZD8931;   Drug: Paclitaxel
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • A Study of OPC-262 in Patients With Type 2 Diabetes

    Condition:   Diabetes Type 2
    Interventions:   Drug: OPC-262 2.5 mg;   Drug: OPC-262 5 mg;   Drug: Placebo
    Sponsor:   Otsuka Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer

    Condition:   Esophageal Cancer
    Intervention:   Biological: IMF-001
    Sponsor:   ImmunoFrontier, Inc.
    Not yet recruiting - verified October 2009

  • Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

    Condition:   Adrenal Tumors
    Intervention:   Procedure: RFA
    Sponsor:   Mie University
    Recruiting - verified October 2009

  • Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

    Condition:   Influenza
    Intervention:   Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
    Sponsors:   Novartis;   Novartis Vaccines
    Active, not recruiting - verified October 2009

  • Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: MP-513;   Drug: Placebo of MP-513
    Sponsor:   Mitsubishi Tanabe Pharma Corporation
    Recruiting - verified October 2009

  • Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

    Conditions:   Cancer;   Non Small Cell Lung Cancer;   Epithelial Ovarian Cancer
    Interventions:   Drug: AZD0530;   Drug: Carboplatin;   Drug: paclitaxel
    Sponsor:   AstraZeneca
    Not yet recruiting - verified October 2009

  • Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

    Conditions:   End Stage Renal Disease;   Hyperparathyroidism, Secondary
    Intervention:  
    Sponsor:   Kyowa Hakko Kirin Company, Limited
    Active, not recruiting - verified October 2009

  • A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

    Condition:   Sleep Initiation and Maintenance Disorders
    Interventions:   Drug: FK199B;   Drug: Zolpidem
    Sponsor:   Astellas Pharma Inc
    Completed - verified October 2009

  • A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members

    Conditions:   Kidney Neoplasm;   Kidney Stone;   Ureteral Tumor;   Ureteral Stricture;   Renal Insufficiency
    Intervention:   Procedure: Restored Kidney Transplant Between Family Members
    Sponsor:   Tokushukai Medical Group
    Recruiting - verified October 2009

  • A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

    Condition:   Esophageal Cancer
    Intervention:   Biological: peptide
    Sponsors:   University of Yamanashi;   Human Genome Center, Institute of Medical Science, University of Tokyo
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials